Burning Rock Biotech (BNR) Total Non-Current Liabilities (2019 - 2026)

Burning Rock Biotech's Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 43.36% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $6.0 million (up 43.36% YoY), while the FY2025 annual figure was $5.5 million, up 4.24% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $6.0 million, up from $5.4 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $11.8 million in Q2 2024, with the low at $1.1 million in Q4 2023.
• The 5-year median for Total Non-Current Liabilities is $4.3 million (2025), against an average of $5.3 million.
• The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities tumbled 87.88% in 2023, then surged 847.91% in 2024.
• Burning Rock Biotech's Total Non-Current Liabilities stood at $2.5 million in 2022, then slumped by 54.02% to $1.1 million in 2023, then surged by 365.17% to $5.3 million in 2024, then rose by 1.15% to $5.4 million in 2025, then climbed by 11.91% to $6.0 million in 2026.
• Business Quant data shows BNR's Total Non-Current Liabilities at $6.0 million in Q1 2026, $5.4 million in Q4 2025, and $3.9 million in Q3 2025.